268 related articles for article (PubMed ID: 31976335)
1. Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling.
Long L; Li Y; Yu S; Li X; Hu Y; Long T; Wang L; Li W; Ye X; Ke Z; Xiao H
J Diabetes Res; 2019; 2019():4875421. PubMed ID: 31976335
[TBL] [Abstract][Full Text] [Related]
2. Scutellarin inhibits high glucose-induced and hypoxia-mimetic agent-induced angiogenic effects in human retinal endothelial cells through reactive oxygen species/hypoxia-inducible factor-1α/vascular endothelial growth factor pathway.
Wang D; Wang L; Gu J; Yang H; Liu N; Lin Y; Li X; Shao C
J Cardiovasc Pharmacol; 2014 Sep; 64(3):218-27. PubMed ID: 25192544
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
Wang J; Tan J; Luo J; Huang P; Zhou W; Chen L; Long L; Zhang LM; Zhu B; Yang L; Deng DY
J Nanobiotechnology; 2017 Mar; 15(1):18. PubMed ID: 28249594
[TBL] [Abstract][Full Text] [Related]
4. KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF.
Chen X; Li J; Li M; Zeng M; Li T; Xiao W; Li J; Wu Q; Ke X; Luo D; Tang S; Luo Y
Diabetes Obes Metab; 2013 Mar; 15(3):224-33. PubMed ID: 22958404
[TBL] [Abstract][Full Text] [Related]
5. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
Liu X; Li J; Li X
Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
[TBL] [Abstract][Full Text] [Related]
6. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
Mei X; Zhang T; Ouyang H; Lu B; Wang Z; Ji L
Biochem Pharmacol; 2019 Jan; 159():82-95. PubMed ID: 30447218
[TBL] [Abstract][Full Text] [Related]
7. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis.
Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L
Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.
Ding Q; Tian XG; Li Y; Wang QZ; Zhang CQ
World J Gastroenterol; 2015 Aug; 21(32):9566-76. PubMed ID: 26327764
[TBL] [Abstract][Full Text] [Related]
12. Lonicerae Japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis.
Zhou L; Zhang T; Lu B; Yu Z; Mei X; Abulizi P; Ji L
J Ethnopharmacol; 2016 Aug; 189():117-25. PubMed ID: 27196298
[TBL] [Abstract][Full Text] [Related]
13. Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism.
Gong CY; Yu ZY; Lu B; Yang L; Sheng YC; Fan YM; Ji LL; Wang ZT
Vascul Pharmacol; 2014 Sep; 62(3):134-42. PubMed ID: 24846859
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy.
Xie H; Zhang C; Liu D; Yang Q; Tang L; Wang T; Tian H; Lu L; Xu JY; Gao F; Wang J; Jin C; Li W; Xu G; Xu GT; Zhang J
Diabetologia; 2021 Jan; 64(1):211-225. PubMed ID: 33104828
[TBL] [Abstract][Full Text] [Related]
15. Activation of the VEGF-A/ERK/PLA2 Axis Mediates Early Retinal Endothelial Cell Damage Induced by High Glucose: New Insight from an In Vitro Model of Diabetic Retinopathy.
Giurdanella G; Lupo G; Gennuso F; Conti F; Furno DL; Mannino G; Anfuso CD; Drago F; Salomone S; Bucolo C
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33065984
[TBL] [Abstract][Full Text] [Related]
16. Kaempferol inhibited VEGF and PGF expression and in vitro angiogenesis of HRECs under diabetic-like environment.
Xu XH; Zhao C; Peng Q; Xie P; Liu QH
Braz J Med Biol Res; 2017 Mar; 50(3):e5396. PubMed ID: 28273207
[TBL] [Abstract][Full Text] [Related]
17. Scutellarin inhibits translocation of protein kinase C in diabetic thoracic aorta of the rat.
Su Y; Liu W; Ma L; Liu X; Liu Z; Zhu B
Clin Exp Pharmacol Physiol; 2012 Feb; 39(2):136-40. PubMed ID: 22092277
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor.
Wang W; Ma X; Han J; Zhou M; Ren H; Pan Q; Zheng C; Zheng Q
PLoS One; 2016; 11(1):e0146197. PubMed ID: 26730961
[TBL] [Abstract][Full Text] [Related]
19. Gambogic acid ameliorates diabetes-induced proliferative retinopathy through inhibition of the HIF-1α/VEGF expression via targeting PI3K/AKT pathway.
Cui J; Gong R; Hu S; Cai L; Chen L
Life Sci; 2018 Jan; 192():293-303. PubMed ID: 29129773
[TBL] [Abstract][Full Text] [Related]
20. Scutellarin ameliorates high glucose-induced vascular endothelial cells injury by activating PINK1/Parkin-mediated mitophagy.
Xi J; Rong Y; Zhao Z; Huang Y; Wang P; Luan H; Xing Y; Li S; Liao J; Dai Y; Liang J; Wu F
J Ethnopharmacol; 2021 May; 271():113855. PubMed ID: 33485979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
